Do we have new preventive strategies for optimizing cardiovascular health in women?

References

• Sacco RL, Roth GA, Reddy KS. The heart of 25 by 25: achieving the goal of reducing global and regional premature deaths from cardiovascular diseases and stroke: a modeling study from the American Heart Association and World Heart Federation. Circulation 2016;133:e674–90
   PubMed Web of Science ®Google Scholar
• Sharma S, Wood MJ. The global burden of cardiovascular disease in women. Curr Treat Options Cardiovasc Med 2018;20:81
   PubMedGoogle Scholar
• Bairey Merz CN, Andersen H, Sprague E. Knowledge, attitudes, and beliefs regarding cardiovascular disease in women: The Women’s Heart Alliance. J Am Coll Cardiol 2017;70:123–32
   PubMed Web of Science ®Google Scholar
• McSweeney JC, Rosenfeld AG, Abel WM, et al. Preventing and experiencing ischemic heart disease as a woman: state of the science. A scientific statement from the American Heart Association. Circulation 2016;133:1302–31
   PubMed Web of Science ®Google Scholar
• Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women – 2011 update: a guideline from the American Heart Association. Circulation 2011;123:1243–62
   PubMed Web of Science ®Google Scholar
• Bushnell C, McCullough LD, Awad IA, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:1545–88
   PubMed Web of Science ®Google Scholar
• Mosca L, Linfante AH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005;111:499–510
   PubMed Web of Science ®Google Scholar
• Goff DC, Jr, Lloyd-Jones DM, Bennett G, et al. for the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:S49–S73
   PubMed Web of Science ®Google Scholar
• Manson JE, Ames JM, Shapiro M, et al. Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society. Menopause 2015;22:247–53
   PubMed Web of Science ®Google Scholar
• Mora S, Wenger NK, Cook NR, et al. Evaluation of the pooled cohort risk equations for cardiovascular risk prediction in a multiethnic cohort from the Women’s Health Initiative. JAMA Intern Med 2018;178:1231–40
   PubMed Web of Science ®Google Scholar
• Collins P, Webb CM, de Villiers TJ, et al. Cardiovascular risk assessment in women – an update. Climacteric 2016;19:329–36
   PubMed Web of Science ®Google Scholar
• Shifren JL, Rifai N, Desindes S, et al. A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women. J Clin Endocrinol Metab 2008;93:1702–10
   PubMed Web of Science ®Google Scholar
• Kurtz EG, Ridker PM, Rose LM, et al. Oral postmenopausal hormone therapy, C-reactive protein, and cardiovascular outcomes. Menopause 2011;18:23–9
   PubMed Web of Science ®Google Scholar
• Kryczka KE, Kruk M, Piotrowski W, et al. Menopause improves the predictive value of common cardiovascular risk scores in women with premature coronary artery disease. Menopause 2018;25:408–17
   PubMed Web of Science ®Google Scholar
• Zoet GA, Meun C, Benschop L, et al. Cardiovascular riskprofilE – Imaging and gender specific disorders (CREw-IMAGO): rationale and design of a multicenter cohort study. BMC Womens Health 2017;17:60
   PubMed Web of Science ®Google Scholar
• Greenland P, Blaha MJ, Budoff MJ, et al. Coronary calcium score and cardiovascular risk. J Am Coll Cardiol 2018;72:434–47
   PubMed Web of Science ®Google Scholar
• Hong JC, Blankstein R, Shaw LJ. Implications of coronary artery calcium testing for treatment decisions among statin candidates according to the ACC/AHA Cholesterol Management Guidelines. A cost-effectiveness analysis. JACC Cardiovascular Imaging 2017;10:938–52
   PubMed Web of Science ®Google Scholar
• Kavousi M, Desai CS, Ayers C, et al. Prevalence and prognostic implications of coronary artery calcification in low-risk women: a meta-analysis. JAMA 2016;316:2126–34
   PubMed Web of Science ®Google Scholar
• Poornima IG, Mackey RH, Allison MA, et al. WHI and WHI CAC Study Investigators. Coronary artery calcification (CAC) and post-trial cardiovascular events and mortality within the Women’s Health Initiative (WHI) estrogen-alone trial. J Am Heart Assoc 2017;6:pii–e006887
   Web of Science ®Google Scholar
• Shaw LJ, Min JK, Nasir K, et al. Sex differences in calcified plaque and long-term cardiovascular mortality: observations from the CAC Consortium. Eur Heart J 2018;39:3737–5
   Web of Science ®Google Scholar
• US Preventive Services Task Force. Risk assessment for cardiovascular disease with nontraditional risk factors. US Preventive Services Task Force Recommendation Statement. JAMA 2018;320:272–80
   PubMed Web of Science ®Google Scholar
• Lewis JR, Schousboe JT, Lim WH, et al. Long-term atherosclerotic vascular disease risk and prognosis in elderly women with abdominal aortic calcification on lateral spine images captured during bone density testing: a prospective study. J Bone Miner Res 2018;33:1001–10
   PubMed Web of Science ®Google Scholar
• Polonsky TS, Greenland P. Breast arterial calcification. Expanding the reach of cardiovascular prevention. Circulation 2017;135:499–501
   PubMed Web of Science ®Google Scholar
• Hendriks EJ, de Jong PA, van der Graaf Y, et al. Breast arterial calcifications: a systematic review and meta-analysis of their determinants and their association with cardiovascular events. Atherosclerosis 2015;239:11–20
   PubMed Web of Science ®Google Scholar
• Margolies L, Salvatore M, Hecht HS, et al. Digital mammography and screening for coronary artery disease. JACC Cardiovasc Imaging 2016;9:350–60
   PubMed Web of Science ®Google Scholar
• Wilmot KA, O’Flaherty M, Capewell S, et al. Coronary heart disease mortality declines in the United States from 1979 through 2011. Evidence for stagnation in young adults, especially women. Circulation 2015;132:997–1002
   PubMed Web of Science ®Google Scholar
• Nabel EG. Heart disease prevention in young women. Sounding an Alarm. Circulation 2015;132:989–91
   PubMedGoogle Scholar
• Brown HL, Warner JJ, Gianos E, et al. Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: a Presidential Advisory from the American Heart Association and the American College of Obstetricians and Gynecologists. Circulation 2018;137:e843–52
   PubMed Web of Science ®Google Scholar
• Hauspurg A, Ying W, Hubel CA, et al. Adverse pregnancy outcomes and future maternal cardiovascular disease. Clin Cardiol 2018;41:239–46
   PubMed Web of Science ®Google Scholar
• Haas DM, Ehrenthal DB, Koch MA, et al. Pregnancy as a window to future cardiovascular health: Design and implementation of the nuMoM2b Heart Health Study. Am J Epidemiol 2016;183:519–53
   PubMed Web of Science ®Google Scholar
• Abbasi J. To prevent cardiovascular disease, pay attention to pregnancy complications. JAMA 2018;320:1741–3
   PubMed Web of Science ®Google Scholar
• Yeh ETH, Chang HM. Oncocardiology – Past, Present, and Future. JAMA Cardiol 2016;1:1066–72
   PubMed Web of Science ®Google Scholar
• Armenian SH, Lacchetti C, Barac A, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. JCO 2017;35:893–911
   PubMed Web of Science ®Google Scholar
• Mehta LS, Watson KE, Barac A, et al. On behalf of the American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research. Cardiovascular disease and breast cancer: where these entities intersect: a Scientific Statement from the American Heart Association. Circulation 2018;137:e30–66
   PubMed Web of Science ®Google Scholar
• Khosrow-Khayar F, Filion KB, Al-Qurashi S, et al. Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials. Ann Oncol 2017;28:487–96
   PubMed Web of Science ®Google Scholar
• Sindzinski A. Risk of heart disease in breast cancer patients receiving estrogen-deprivation therapy. J Natl Cancer Inst 2017;1:109
   Google Scholar
• Goldvaser H, Barnes TA, Seruga B, et al. Toxicity of extended adjuvant therapy with aromatase inhibitors in early breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2018; 110:31–9
   Google Scholar
• Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the Menopause: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2015;100:3975–4011
   PubMed Web of Science ®Google Scholar
• The NAMS. Hormone therapy position statement advisory panel. The 2017 hormone therapy position statement of the North American Menopause Society. Menopause 2017;24:728–53
   PubMed Web of Science ®Google Scholar
• Baber RJ, Panay NJ, Fenton A et al. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 2016;19:109–50
   PubMed Web of Science ®Google Scholar
• Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA 2013;310:1353–68
   PubMed Web of Science ®Google Scholar
• Manson JE, Aragaki AK, Rossouw JE, et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women’s Health Initiative randomized trials. JAMA 2017;318:927–38.
   PubMed Web of Science ®Google Scholar
• Stuenkel CA. Timing of menopausal hormone therapy and myocardial infarction. Menopause 2015;22:584–6
   PubMed Web of Science ®Google Scholar
• Stuenkel CA. Deciphering the complex relationship between menopause and heart disease: 25 years and counting. Menopause 2018;25:955–62
   PubMed Web of Science ®Google Scholar
• Manson JE, Allison MA, Rossouw JE, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007;356:2591–602
   PubMed Web of Science ®Google Scholar
• Schierbeck LL, Rejnmark L, Tofteng CL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ 2012;345:e6409
   PubMed Web of Science ®Google Scholar
• Harman SM, Black DM, Naftolin F, et al. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med 2014;161:249–60
   PubMed Web of Science ®Google Scholar
• Hodis HN, Mack WJ, Henderson VW, et al. Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med 2016;374:1221–30.
   PubMed Web of Science ®Google Scholar
• US Preventive Services Task Force. Hormone therapy for the primary prevention of chronic conditions in postmenopausal women. JAMA 2017;318:2224–33
   PubMed Web of Science ®Google Scholar
• Committee Opinion No. 698: Hormone Therapy in Primary Ovarian Insufficiency. Committee on gynecologic practice. Obstet Gynecol 2017;129:e134–41
   PubMedGoogle Scholar
• Center for Disease Control and Prevention. Smoking and Tobacco Use. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/quitting/index.htm; Last updated February 1, 2017; Accessed October 25, 2018
   Google Scholar
• Eckel RH, Jakicic JM, Ard JD, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:S76–S99
   PubMed Web of Science ®Google Scholar
• Van Horn L, Carson JA, Appel LJ, et al. American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Stroke Council. Recommended Dietary Pattern to Achieve Adherence to the American Heart Association/American College of Cardiology (AHA/ACC) Guidelines: A Scientific Statement From the American Heart Association. Circulation 2016;134:e505–29
   PubMed Web of Science ®Google Scholar
• Lobelo F, Rohm Young D, Sallis R, et al. American Heart Association Physical Activity Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Clinical Cardiology; Council on Genomic and Precision Medicine; Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Routine assessment and promotion of physical activity in healthcare settings: A Scientific Statement from the American Heart Association. Circulation 2018;137:e495–522
   PubMed Web of Science ®Google Scholar
• Piercy KL, Troiano RP, Ballard RM, et al. The Physical Activity Guidelines for Americans. JAMA 2018;320:2020–8
   PubMed Web of Science ®Google Scholar
• Jensen MD, Ryan DH, Apovian CM, et al. 2013 ACC/AHA/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014;129:S102–S38
   PubMed Web of Science ®Google Scholar
• Kuller LH, Simkin-Silverman LR, Wing RR, et al. Women’s Healthy Lifestyle Project: a randomized clinical trial: results at 54 months. Circulation 2001;103:32–7
   PubMed Web of Science ®Google Scholar
• Li Y, Pan A, Wang DD, et al. Impact of healthy lifestyle factors on life expectancies in the US population. Circulation 2018;138:345–55
   PubMed Web of Science ®Google Scholar
• Samieri C, Perier MC, Gaye B, et al. Association of cardiovascular health level in older age with cognitive decline and incident dementia. JAMA 2018;320:657–64
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018 2017;71:e127–248
   PubMed Web of Science ®Google Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force. On Practice Guidelines. Circulation 2014;129:S1–S45
   PubMed Web of Science ®Google Scholar
• US Preventive Services Task Force. Statin use for the primary prevention of cardiovascular disease in adults. US Preventive Services Task Force Recommendation Statement. JAMA 2016;316:1997–2007
   PubMed Web of Science ®Google Scholar
• Grundy SM, Stone NJ, Bailey AL, et al. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018;S0735–S1097. 2018; Nov 8. pii: 18)39034-X
   Google Scholar
• American Diabetes Association. 9. Cardiovascular disease and risk management: Standards of Medical Care in Diabetes –2018. Diabetes Care 2018;41:S86–S104
   PubMed Web of Science ®Google Scholar
• Saxon DR, Rasouli N, Eckel RH. Pharmacological prevention of cardiovascular outcomes in diabetes mellitus: established and emerging agents. Drugs 2018;78:203–14
   PubMed Web of Science ®Google Scholar
• Bibbins-Domingo K. US Preventive Services Task Force. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: US Preventive Services Task Force Recommendation Statement. Ann Intern Med 2016;164:836–45
   PubMed Web of Science ®Google Scholar
• Riegel B, Moser DK, Buck HG, et al. Self-care for the prevention and management of cardiovascular disease and stroke. A Scientific Statement for Healthcare Professionals from the American Heart Association. J Am Heart Assoc 2017;6:e006997
   PubMed Web of Science ®Google Scholar